Abbott to pay $385 million to settle lawsuit over baby formula plant operations
The Hill · September 15, 2026Original source ↗

What happened
Abbott Laboratories has agreed to pay $385 million to settle allegations concerning its operation of a manufacturing plant linked to contaminated powdered baby formula. The contamination resulted in the temporary closure of the facility in 2022, leading to a recall of several infant formula brands and impacting the supply chain.
Why it matters
This settlement is significant as it addresses safety concerns related to infant nutrition and supply shortages.
How this story affects people
How does this story affect you if you are a parent of an infant?
The settlement addresses safety concerns regarding the quality of baby formula, which directly impacts the health and nutrition of your child. If you were affected by the recall, this settlement may provide some accountability for the distress caused.
How does this story affect you if you work in the food manufacturing industry?
The case highlights significant regulatory scrutiny and the importance of safety standards in food production. This could lead to changes in operational practices and increased oversight in your workplace.
Want this written about you?
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Get your RippleMore stories
- HealthNew Mexico reports screwworm case in horse before livestock imports from Mexico resume
- HealthPentagon provides new guidance for testosterone testing for service members
- HealthRFK Jr. addresses conference for activist group he founded
- HealthAt least 48 fatalities in Nigeria linked to potentially toxic local alcohol